Search results
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 7 days agoThe submission is based on FDA guidance, which advised that COVID-19 vaccines should be updated to a...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 4 days agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA Today· 16 hours agoCases of the latest COVID-19 variant, also known as KP.3, are on the rise in the United States....
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Reuters via AOL· 7 days agoThe Food and Drug Administration's advisory is in line with European and World Health Organization...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 2 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
Moderna Falls, Though Says Covid/Flu Shot Topped Rivals
Investor's Business Daily· 4 days agoIn a study of about 8,000 people, Moderna's combination vaccine proved it's not inferior to the...
Healthy Returns: What we know about the next round of Covid vaccines
CNBC· 2 days agoA new round of Covid shots will likely reach Americans in the coming months. Here's what we know...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 5 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Moderna (MRNA) COVID-Flu Combo Jab Meets Late-Stage Study Goal
Zacks via Yahoo Finance· 3 days agoData from a late-stage study shows that Moderna's (MRNA) experimental COVID-19-influenza combination...
Moderna director Afeyan sells over $30 million in company stock By Investing.com
Investing.com· 3 days agoModerna , Inc. (NASDAQ:MRNA) Director Noubar Afeyan has sold a significant number of company shares,...